Clinical Trials Browser

Has results × Recurrence × Gemtuzumab × Clear all

NCT04070768 2025-05-04

Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113

Phase 1 Completed

18 enrolled 15 charts

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute